Boston Scientific Makes Two Deals in March

Boston Scientific Makes Two Deals in March

by | Mar 23, 2018 12:50 pm | Medical Devices

Boston Scientific Corporation (NYSE: BSX) has had a busy month, and March 2018 isn’t over yet. On March 5, the medical device maker disclosed a deal for EMcision, Limited, based in Montreal, Quebec. The acquisition will expand the Boston Scientific Endoscopy portfolio to include the Habib EndoHPB probe, a novel endoscopic bipolar radiofrequency device, which coagulates tissue in the gastrointestinal tract. The Habib probe has been cleared by the U.S. FDA and received CE mark in the European Union. Although financial terms for the deal were not disclosed, BSX said the acquisition is expected to be immaterial to earnings per share in 2018 on an adjusted and GAAP basis and accretive... Read More »
Boston Scientific Makes Two Deals in March

Laborie Medical Takes Over Congentix Medical

by | Mar 15, 2018 9:31 pm | Medical Devices

Cogentix Medical, Inc. (NASDAQ: CGNT) is a global medical device company that offers products for flexible endoscopy and the treatment of overactive bladder and urinary incontinence. Its majority share owners, Accelmed Growth Partners LP and Mr. Lewis Pell, who collectively own approximately 60% of Cogentix Medical’s outstanding common stock, agreed to an offer of $3.85 per share (approximately $214 million) from Laborie Medical Technologies (LMT), a subsidiary of Patricia Industries.  The offer of $3.85 per share in cash represents a premium of 28% over the average closing price of Cogentix Medical common stock over the last 30 days. In July 2017, Cogentix paid $671,817 (£515,000)... Read More »

2017 Biggest Healthcare Deals by Sector

by | Jan 29, 2018 10:09 am | Behavioral Health Care, Biotechnology, eHealth, Long-Term Care, Managed Care, Medical Devices, Other Services, Pharmaceuticals, Physician Medical Groups, Rehabilitation

2017 was another big year for billion-dollar healthcare transactions. Among the deals that disclosed prices, 44 topped the billion-dollar mark, for a total of approximately $263.1 billion. Although that number seems high, there were 50 billion-dollar deals announced in 2015, although those totaled a slightly lower $240.1 billion. 2016 posted lower totals for both the number of billion-dollar deals (39) and combined prices ($194.1 billion). Of course the biggest healthcare deal in 2017 was the $77 billion acquisition of Aetna Inc. (NYSE: AET) by CVS Health (NYSE: CVS). But there were many more sizable transactions across the sectors, as the chart below illustrates. See how many you remember... Read More »
Boston Scientific Makes Two Deals in March

Stryker Buys Entellus Medical

by | Dec 18, 2017 4:36 pm | Medical Devices

Deals for medical device companies in 2017 are keeping pace with the previous year’s deal volume, more or less. With two weeks left in the year, 107 transactions in the Medical Device category have been announced and about $48.0 billion in spending. Deal volume is 5% lower than the 113 transactions announced for all of 2016 in this sector. The dollar volume is 22% lower than last year’s $61.8 billion. The latest deals announced in December include Stryker Corp.’s (NYSE: SYK) $709.6 million acquisition of Entellus Medical (NASDAQ: ENTL), a global medical technology company focused on delivering superior patient and physician experiences through products designed for the... Read More »
Boston Scientific Makes Two Deals in March

Merit Medical Scores Assets from BD and Bard

by | Nov 17, 2017 5:13 pm | Medical Devices

Just after the release of the third quarter results, Merit Medical Systems, Inc. (NASDAQ: MMSI) announced an asset purchase agreement with two of its competitors. Merit has made two other similar acquisitions in 2017. The company entered into an asset purchase agreement with Becton, Dickinson and Company (NYSE: BDX) and C.R. Bard, Inc. (NYSE: BCR) to acquire various assets in relation to BD’s $24 billion acquisition of C.R. Bard, announced on April 23, 2017. The acquired assets include soft tissue core needle biopsy products currently sold by BD under the trade names of Achieve™ Programmable Automatic Biopsy System, Temno™ Biopsy System and Tru-Cut™ Biopsy Needles, which are currently sold... Read More »

CryoLife Misses Q3 Revenues, Buys JOTEC

by | Oct 11, 2017 6:04 pm | Medical Devices

Third quarter earnings season is off to a bad start for Cryolife, Inc. (NYSE:CRY), maker of medical devices and tissue processing systems focused on cardiac and vascular surgery. CRY stock slumped on Wednesday, October 11, when the company reported Q3 revenues of $45.1 million, well below its previously announced guidance of $46.5 million to $47.5 million. Not even an acquisition turned the stock northward, and it stayed down about 16% throughout the day. On October 10, Cryolife announced the acquisition of German medical device developer JOTEC AG, which makes technologically differentiated endovascular stent grafts, and cardiac and vascular surgical grafts, focused on... Read More »